How are energy investors positioned?
David J. Croyle, the Chief Medical (TASE:BLWV) Officer and a significant shareholder of Callan JMB Inc. (NASDAQ:CJMB), recently acquired 25,000 shares of the company’s common stock. The transaction, which took place on March 27, 2025, was valued at approximately $112,500, with each share purchased at $4.50. The stock currently trades at $3.92, near its 52-week low of $3.38, in a year that has seen prices reach as high as $7.76. According to InvestingPro, the stock shows high price volatility, making insider transactions particularly noteworthy for investors.
Following this acquisition, Croyle holds a total of 775,000 shares, reflecting his continued confidence in the company’s prospects. The shares were acquired through Croyle’s Rollover IRA, indicating a direct investment in Callan JMB’s future. The micro-cap company, valued at $18.89 million, maintains strong liquidity with a current ratio of 2.59, though InvestingPro analysis indicates additional factors worth considering, with 6 more exclusive insights available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.